Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B0VD
|
|||
| Former ID |
DIB010246
|
|||
| Drug Name |
MORAb-022
|
|||
| Synonyms |
Antibody (inflammation/autoimmune disease), Morphotek
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1 | [1] | |
| Rheumatoid arthritis [ICD-11: FA20] | Phase 1 | [2] | ||
| Company |
Eisai
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01357759) Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of Morphotek. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.